In our RROS, we found that tumor-infiltrating lymphocyte counts are associated with peculiar gene expression patterns and bear prognostic information in ovarian cancer: CD4+ and CD45+ immune cell infiltration showed significant predictive power for overall survival. This evidence concerns the gene CD4 and ovarian cancer.